VRTX
VERTEX PHARMACEUTICALS INC / MA
NASDAQ · Healthcare · Biotechnology · US
$549.04
+3.44%Leverage
- Debt / equity
- 0.31x
- Net debt / equity
- 0.07x
- Debt / assets
- 0.20x
- Debt / EBITDA
- 1.30x
- Net debt / EBITDA
- 0.30x
Liquidity & coverage
- Current ratio
- 2.34x
- Quick ratio
- 1.89x
- Cash ratio
- 1.26x
- Interest coverage
- 111.93x
- EBITDA / interest
- 126.38x
- Working capital
- $6.7B
Cash & dividend
- FCF / debt
- 0.49x
- Cash flow / debt
- 0.57x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026